Market Overview

NovaBay Pharmaceuticals to Hold Second Quarter 2018 Conference Call on August 7, 2018

Share:

NovaBay®
Pharmaceuticals, Inc.
(NYSE:NBY), a
biopharmaceutical company focusing on commercializing prescription
Avenova® for the domestic eye care market, announces that it
will report second quarter 2018 financial results after market close on
Tuesday, August 7. Management will hold an investment community
conference call that day to discuss financial results and provide a
Company update.

DATE:     Tuesday, August 7
TIME: 4:30 p.m. ET / 1:30 p.m. PT
DIAL IN: 800-608-8202 from within the U.S.
702-495-1913 from outside the U.S.
Enter conference identification number 1078758

The live call also will be available at http://novabay.com/investors/events.
A replay of the call will be available beginning two hours after its
completion through 11:59 p.m. Eastern time August 13, 2018, by dialing
855-859-2056 from within the U.S. or 404-537-3406 from outside the U.S.
and entering the conference identification number 1078758. The call will
also be archived at http://novabay.com/investors/events.

About NovaBay Pharmaceuticals, Inc.: Going Beyond Antibiotics®

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing on
commercializing and developing its non-antibiotic anti-infective
products to address the unmet therapeutic needs of the global, topical
anti-infective market with its two distinct product categories: the
NEUTROX® family of products and the AGANOCIDE® compounds. The Neutrox
family of products includes AVENOVA® for the eye care market,
NEUTROPHASE® for wound care market, and CELLERX® for the aesthetic
dermatology market. The Aganocide compounds, still under development,
have target applications in the dermatology and urology markets.

Socialize and Stay informed on NovaBay's progress:
Like
us on 
Facebook
Follow
us on 
Twitter
Connect
with NovaBay on 
LinkedIn
Join
us on 
Google+
Visit
NovaBay's 
Website

NovaBay Contacts
For NovaBay Avenova purchasing information:
Please
Call us toll free: 1-800-890-0329 or email sales@avenova.com.
www.Avenova.com

View Comments and Join the Discussion!